QBTS: the balance sheet

MyFinsight

For the year ending 2025-12-31, QBTS has $915,813K in assets. $63,583K in debts. $635,347K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
4237.90%
Quick Ratio
4224.78%
Cash Ratio
3004.29%
Debt to Asset Ratio
6.94%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Marketable investment securities
Operating lease right-of-use ass...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive ...
Others

Balance Sheets	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	635,347	177,980	-	-
Cash	-	-	41,307	7,065
Marketable investment securities	249,134	-	-	-
Trade accounts receivable, net of allowance for credit losses of 1 and 176	1,587	1,420	1,652	757
Research incentive receivable	-	-	0	264
Inventories	2,776	1,686	2,078	2,196
Prepaid expenses and other current assets	7,388	3,954	2,009	3,643
Deferred offering costs	-	-	-	0
Total current assets	896,232	185,040	47,046	13,925
Property and equipment, net	7,841	4,133	2,551	2,294
Operating lease right-of-use assets	6,518	7,261	8,223	9,133
Intangible assets, net	915	490	179	244
Other non-current assets, net	4,307	2,929	1,357	1,351
Total assets	915,813	199,853	59,356	26,947

Trade accounts payable	950	815	1,465	3,756
Accrued expenses and other current liabilities	15,838	8,784	5,343	6,687
Current portion of operating lease liabilities	1,448	1,512	1,374	1,533
Loans payable, net, current	134	348	399	1,671
Deferred revenue, current	2,778	18,686	2,669	1,781
Promissory notes - related party	-	-	0	420
Total current liabilities	21,148	30,145	11,250	15,848
Warrant liabilities	0	69,875	1,630	1,892
Operating lease liabilities, net of current portion	6,050	6,389	7,028	7,301
Loans payable, net, non-current	35,825	30,128	63,850	7,811
Deferred revenue, non-current	560	670	79	9
Other noncurrent liabilities	-	-	-	0
Total liabilities	63,583	137,207	83,837	32,861
Non-redeemable convertible preferred stock, no par value nil shares and 122,564,333 shares authorized as of december31, 2022 and december31, 2021, respectively nil shares and 122,564,333 shares issued and outstanding as of december31, 2022 and december31, 2021, respectively	-	-	-	0
Common stock, par value 0.0001 per share 675,000,000 shares authorized at both december31, 2025 and december31, 2024 358,741,605 shares and 266,595,867 shares issued and outstanding as of december31, 2025 and december31, 2024, respectively	35	27	16	11
Additional paid-in capital	1,843,218	700,069	469,081	381,274
Accumulated deficit	-982,002	-626,940	-483,061	-376,797
Accumulated other comprehensive loss	-9,021	-10,510	-10,517	-10,402
Total stockholders' equity	852,230	62,646	-24,481	-5,914
Total liabilities and stockholders equity	915,813	199,853	59,356	26,947

Unit: Thousand (K) dollars (except for numbers of shares and EPS).

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets